A small molecule has entered a novel clinical trial for cancer immunotherapy. The molecule inhibits an enzyme called MALT1 that plays a critical role in suppressing immune reactions against tumor cells. Preclinical studies showed that blocking MALT1…
Researchers at Helmholtz Zentrum München and the University of Bochum received this year's Erwin Schrödinger Prize in recognition of their efforts to develop a cure for parasitic diseases such as Chagas disease with a new compound. The prize is…
Helmholtz Zentrum München is coordinating a European network to train the next generation of researchers in drug development.
Researchers at Helmholtz Zentrum München and Ludwig-Maximilians-University (LMU) mapped the signaling network in plants and discovered novel insights about how plants process information about their environment. This gives new potential to strategies…
Wanted: Established, leading principal investigator with a track-record of significant research achievements in the last 10 years. Found: At Helmholtz Zentrum München. Magdalena Götz and Marcus Conrad both receive an ERC Advanced Grant for their…
Gut bacteria are central to human health. They are a key player in contributing to immune regulation, pathogen protection, food and drug metabolism, and vitamin synthesis. Another supporting actor in the gut, however, are bacteriophages or short…
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here: